RECOVERY Respiratory Support (RS)

Ventilation strategies in COVID-19 – CPAP, high-flow, and standard care

Type: Interventional

Site and lead:

  • MFT: Dr Andrew Bentley

Patient group: All COVID-19 patients


  • CPAP

Funder: NIHR Central Commissioning Facility (CCF)

Sponsor: University of Warwick

More about RECOVERY RS

The purpose of this trial is to test if existing or new drugs can help patients hospitalised with confirmed COVID-19.

The therapies being tested will be evaluated to see if they are safe and effective when added to the usual standard of care.

RECOVERY has an ‘adaptive’ design, meaning it can test new therapies as they become available. The aim is for national data to be available to inform patient treatment within three months.